Sutro Biopharma
STRO
STRO
117 hedge funds and large institutions have $302M invested in Sutro Biopharma in 2024 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 49 increasing their positions, 32 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
18% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 17
3% more funds holding
Funds holding: 114 → 117 (+3)
6.13% less ownership
Funds ownership: 91.67% → 85.54% (-6.1%)
Holders
117
Holding in Top 10
3
Calls
$54K
Puts
$14K
Top Buyers
| 1 | +$23.1M | |
| 2 | +$18.1M | |
| 3 | +$4.43M | |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$4.21M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$4.12M |
Top Sellers
| 1 | -$14.4M | |
| 2 | -$14.3M | |
| 3 | -$13.9M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$11.9M |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
-$3.54M |